- Gastroenterology Advisor

Crohn disease

CROHN DISEASE

Latest Articles

Intravenous Vedolizumab Associated With Improved Outcomes in Crohn Disease

Vedolizumab has demonstrated efficacy among individuals with moderate to severe active Crohn disease, according to a study recently published in Gastroenterology. Improvements were observed in radiologic, histologic, and endoscopic outcomes.  This open-label, phase-3b trial (VERSIFY; ClinicalTrials.gov identifier: NCT02425111) included 101 individuals who had experienced active Crohn disease for 3 months or more between March 2015…